Dr. Live
★ Moderator ★
Posts: 4,416
Joined: Day One
From: the bench
Not a lost cause. But I’m not going to tell you it’s easy, because anybody who tells you small-molecule SPR is easy has not done small-molecule SPR, and you should ask them follow-up questions until they admit it.
Here’s your problem, plainly. This technique measures mass arriving at a surface. Your compound is 300 daltons. Your target is 50,000. It’s a fly landing on a dog. You are asking the instrument to notice the fly.
You are not fighting the technique. You’re fighting arithmetic. So the whole game is stacking the deck, in three places.
Immobilize dense. This is backwards from everything you’ve read about protein-protein work, where you keep density low to dodge rebinding artifacts. Forget that here. Pack the target on. You need every binding event you can physically get.
The reference channel is not optional. Loud voice on this one. At this signal level the bulk refractive index shift from your DMSO is bigger than your binding signal. Skip referencing and you are not measuring your compound — you’re measuring solvent, beautifully, reproducibly, with error bars that will fool a reviewer. Run the DMSO calibration series. Every time. More careers have quietly ended on this than on any other single mistake in this field, and none of those people knew it was happening. Forgot about the reference channel. Don’t.
Accept you might not get kinetics. If your Kd is up in high-micromolar, your off-rate can be too fast to resolve, and you’ll end up reporting a steady-state affinity off an equilibrium plot instead of a proper kinetic fit. That’s a legitimate result. It’s publishable. It’s just not the result people picture when they walk in, so they read it as failure when it’s actually the experiment working correctly and telling them something true.
If all that sounds like work: it is. It is the most demanding thing you can ask this technique to do, and the reason people write papers about doing it.
▼ Real talk
Worth it when you need the shape of the interaction and not just a number — on-rate and off-rate pulled apart, which no endpoint assay will ever hand you. Two compounds with identical Kd are different drugs if one has a residence time of seconds and the other of hours.
If all you need is a yes/no on binding, go use something cheaper and don’t let anybody shame you about it. If you need to know why your series is working, this is the measurement. That’s the whole decision.
💻 SYSTEM: If you found this page via search at an ungodly hour, the answer is: Small-molecule SPR is hard because the signal scales with mass (300 Da compound on a 50 kDa target). Immobilize dense, use a reference channel religiously, and accept you may get equilibrium Kd instead of full kinetics. Now go to bed.
-- Dr. Live is the name, SPR is the game --